Näky review

You can work out what a low dose costs here before you sign up, which is rare: every product, every plan length, every total, spelled out where you can read them, and the month-to-month rate disclosed alongside the advertised prepay figure rather than instead of it. That transparency is what makes the finding checkable: the GLP-1 Microdose costs more per month than the standard-dose injection of the same molecule, and more again over three months. The catalog is worth knowing about, and the microdose is the one product on it a low-dose reader should think twice about. Every advertised starting figure is a prepay rung.

Vs median

$20/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

Näky says it uses a 503A pharmacy, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.

Näky, operated by Naky Health LLC, is a Shopify storefront that sells compounded GLP-1 care as discrete catalog products rather than behind a quiz: compounded semaglutide, compounded tirzepatide, oral semaglutide drops, the branded Wegovy pill, a GLP-1 Microdose program, and sermorelin and NAD+ under a longevity heading. Care is entirely online with board-certified providers, and medication is prepared by U.S. state-licensed 503A pharmacies following USP <797> sterile compounding standards. Its terms disclose that Naky Health LLC is itself one of the dispensing options inside the pharmacy network it refers patients to.

The microdose costs MORE than the standard semaglutide injection — $195 against $185 month-to-month, and $555 against $495 over three months. Choosing less drug is a $10-a-month premium here, on Näky's own published figures

• Every advertised "starting at" figure is a prepay rung rather than a monthly rate: semaglutide is marketed at $145 and costs $185 month-to-month, tirzepatide is marketed at $265 and costs $295
• The branded oral line carries a compulsory $125/mo membership disclosed only in body copy beneath the dose table, turning an advertised $149 into $274 at the lowest dose
• The site-wide "same price at every dose" banner is contradicted by its own branded-pill page, which doubles from $149 to $299 between the second and third dose
• Naky Health LLC is itself a dispensing pharmacy inside the network it refers patients to, which is disclosed only in the terms of service
• No list of states served is published anywhere, despite the catalog being directly purchasable
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Näky is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing semaglutide
• Oral semaglutide (Rybelsus)
• What a flat price costs at a low dose
• The true annual cost of a plan